Michael Diamond to Pneumonia, Viral
This is a "connection" page, showing publications Michael Diamond has written about Pneumonia, Viral.
Connection Strength
0.190
-
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020 11; 21(11):1327-1335.
Score: 0.029
-
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell. 2020 10 01; 183(1):169-184.e13.
Score: 0.029
-
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice. Cell Host Microbe. 2020 09 09; 28(3):465-474.e4.
Score: 0.028
-
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies. Cell. 2020 08 06; 182(3):744-753.e4.
Score: 0.028
-
The Challenges of Vaccine Development against a New Virus during a Pandemic. Cell Host Microbe. 2020 05 13; 27(5):699-703.
Score: 0.028
-
Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics. Cell Host Microbe. 2020 11 11; 28(5):638-645.
Score: 0.007
-
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 11 20; 370(6519):950-957.
Score: 0.007
-
Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020 08; 584(7821):443-449.
Score: 0.007
-
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nat Med. 2020 09; 26(9):1422-1427.
Score: 0.007
-
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. Cell Host Microbe. 2020 09 09; 28(3):475-485.e5.
Score: 0.007
-
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. J Immunol. 2020 08 15; 205(4):915-922.
Score: 0.007
-
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science. 2020 10 23; 370(6515):426-431.
Score: 0.002
-
Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proc Natl Acad Sci U S A. 2020 08 25; 117(34):20803-20813.
Score: 0.002
-
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
Score: 0.002